Home

venin Africa Marte roche oncology Egoism Consulta politică

Roche and Blueprint Medicines Launch Up-to-$1.7B Partnership to Develop  Cancer Drug Pralsetinib
Roche and Blueprint Medicines Launch Up-to-$1.7B Partnership to Develop Cancer Drug Pralsetinib

Transforming the future of cancer treatment - Roche
Transforming the future of cancer treatment - Roche

Matthias Lutolf on X: "Are you interested in cancer organoids/tumoroids and  their application in drug discovery and development as well as in  personalized medicine? Check out this open postdoctoral position at the
Matthias Lutolf on X: "Are you interested in cancer organoids/tumoroids and their application in drug discovery and development as well as in personalized medicine? Check out this open postdoctoral position at the

Science 37 teams up with Roche's Foundation Medicine to boost home-based  oncology trials | Fierce Biotech
Science 37 teams up with Roche's Foundation Medicine to boost home-based oncology trials | Fierce Biotech

Developmental Therapeutics | ESMO
Developmental Therapeutics | ESMO

Roche Elevates Open Rates to 75% with Mitto Conversations | Mitto
Roche Elevates Open Rates to 75% with Mitto Conversations | Mitto

Oncology assays
Oncology assays

Roche acquires oncology EHR company Flatiron Health for $1.9 billion |  Healthcare IT News
Roche acquires oncology EHR company Flatiron Health for $1.9 billion | Healthcare IT News

Precision oncology enabled by digital solutions
Precision oncology enabled by digital solutions

Precision Oncology: Neue Zusammenarbeit von Roche und USZ
Precision Oncology: Neue Zusammenarbeit von Roche und USZ

Roche | Diagnostics in oncology
Roche | Diagnostics in oncology

Roche Oncology on Viber
Roche Oncology on Viber

Slide 3 of 6 of Copywriter Collective - Harold - Roche oncology ads a3 x 6  | Oncology, Roche, Copywriting
Slide 3 of 6 of Copywriter Collective - Harold - Roche oncology ads a3 x 6 | Oncology, Roche, Copywriting

Roche on X: "The U.S. FDA Oncology Drugs Advisory Committee (ODAC) votes in  favour of our combination treatment for people with previously untreated  diffuse large B-cell lymphoma, an aggressive form of #lymphoma
Roche on X: "The U.S. FDA Oncology Drugs Advisory Committee (ODAC) votes in favour of our combination treatment for people with previously untreated diffuse large B-cell lymphoma, an aggressive form of #lymphoma

Kaiku Health expands collaboration with Roche in digital patient monitoring  and management - Kaiku Health
Kaiku Health expands collaboration with Roche in digital patient monitoring and management - Kaiku Health

Roche Lietuva on LinkedIn: #precisionmedicine
Roche Lietuva on LinkedIn: #precisionmedicine

Alecensa delivers unprecedented phase III results for people with  ALK-positive early-stage lung cancer - Roche - Medical Update Online
Alecensa delivers unprecedented phase III results for people with ALK-positive early-stage lung cancer - Roche - Medical Update Online

Oncology | La Roche-Posay IE
Oncology | La Roche-Posay IE

Roche Awards | NZSO
Roche Awards | NZSO

Roche Oncology Scientific Summit
Roche Oncology Scientific Summit

Roche, pipeline bulging from deal spree, axes 8 oncology and neurology  programs to speed up R&D
Roche, pipeline bulging from deal spree, axes 8 oncology and neurology programs to speed up R&D

Roche FMI landing page
Roche FMI landing page

Roche commercializes NGS AVENIO Tumor Tissue Analysis Kits
Roche commercializes NGS AVENIO Tumor Tissue Analysis Kits

Roche | Oncology
Roche | Oncology

Roche | Oncology
Roche | Oncology